Rezultati

eNauka >  Results >  Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial
Title: Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial
Authors : Peters, Solange; ...; Andric, Zoran G  ; ...; (broj, koautora 26)
Issue Date: 2022
Publication: NATURE MEDICINE
ISSN: 1078-8956 Nature Medicine Search Idenfier
Type: Article
Collation: vol. 28 br. 9 str. 1831-1839
DOI: 10.1038/s41591-022-01933-w
WoS-ID: 000842907100002
Scopus-ID: 2-s2.0-85136993595
PMID: 35995953
PMCID: PMC9499854
URI: https://enauka.gov.rs/handle/123456789/810648
Project: F. Hoffmann-La Roche, Ltd.
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21a+M21a+

94
SCOPUSTM
65
PubMed CentralTM
4
OpenCitations
92
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.